🇺🇸 FDA
Patent

US 11730740

Laureth-4 containing topical formulations

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 11730740 (Laureth-4 containing topical formulations) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCUTIS BIOTHERAPEUTICS, INC.
Grant date
Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/519, A61K31/5377, A61K31/573, A61K38/13